Veradermics MANE
NYSE MANE
$148.48 +4.53 (+3.15%)
As of: Nov 10, 2026 · 12:27 PM EST

Veradermics (MANE) EBT (2025 - 2026)

Updated

Veradermics' EBT came in at -$23.5 million for Q2 2026, compared with -$15.65 million a year earlier.

Analysis

Veradermics (MANE) EBT (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported EBT of -$78.78 million; for FY2025, it was -$70 million.

  • Going back by year, EBT was -$26.49 million in FY2024.
  • The five-year range for quarterly EBT is -$27.23 million (Q1 2026) to -$12.4 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 34.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 4.83 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 2.80 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.06 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.39 Bn
10 Veradermics 6.01 Bn 4.61 Bn - -23.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.50 Mn
Mar 31, 2026 -27.23 Mn
Jun 30, 2025 -15.65 Mn
Mar 31, 2025 -12.40 Mn
API Access

Veradermics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=MANE&period=max&api_key=YOUR_API_KEY